These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 15695591)

  • 61. RANKL-RANK signaling in osteoclastogenesis and bone disease.
    Wada T; Nakashima T; Hiroshi N; Penninger JM
    Trends Mol Med; 2006 Jan; 12(1):17-25. PubMed ID: 16356770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Calcineurin/NFAT signaling pathway mediates titanium particle‑induced inflammation and osteoclast formation by inhibiting RANKL and M‑CSF in vitro.
    Zhang Y; Jiang P; Li W; Liu X; Lu Y; Huang Z; Song K
    Mol Med Rep; 2017 Dec; 16(6):8223-8230. PubMed ID: 28990090
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.
    Mangashetti LS; Khapli SM; Wani MR
    J Immunol; 2005 Jul; 175(2):917-25. PubMed ID: 16002690
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
    Zheng H; Yu X; Collin-Osdoby P; Osdoby P
    J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
    Son A; Kang N; Oh SY; Kim KW; Muallem S; Yang YM; Shin DM
    J Endocrinol; 2019 Sep; 242(3):241-249. PubMed ID: 31319381
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.
    Matsuo K; Galson DL; Zhao C; Peng L; Laplace C; Wang KZ; Bachler MA; Amano H; Aburatani H; Ishikawa H; Wagner EF
    J Biol Chem; 2004 Jun; 279(25):26475-80. PubMed ID: 15073183
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.
    Kwak HB; Lee SW; Jin HM; Ha H; Lee SH; Takeshita S; Tanaka S; Kim HM; Kim HH; Lee ZH
    Blood; 2005 Apr; 105(7):2963-9. PubMed ID: 15585657
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.
    Mandal CC; Das F; Ganapathy S; Harris SE; Choudhury GG; Ghosh-Choudhury N
    J Biol Chem; 2016 Jan; 291(3):1148-61. PubMed ID: 26472929
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast.
    Bai XC; Lu D; Liu AL; Zhang ZM; Li XM; Zou ZP; Zeng WS; Cheng BL; Luo SQ
    J Biol Chem; 2005 Apr; 280(17):17497-506. PubMed ID: 15731115
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isoproterenol Increases RANKL Expression in a ATF4/NFATc1-Dependent Manner in Mouse Osteoblastic Cells.
    Baek K; Park HJ; Baek JH; Kim HR
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling.
    Murakami A; Matsuda M; Harada Y; Hirata M
    J Biol Chem; 2017 May; 292(19):7994-8006. PubMed ID: 28341745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel osteoclast signaling mechanisms.
    Shinohara M; Takayanagi H
    Curr Osteoporos Rep; 2007 Jun; 5(2):67-72. PubMed ID: 17521508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. TNFα Increases RANKL Expression via PGE₂-Induced Activation of NFATc1.
    Park HJ; Baek K; Baek JH; Kim HR
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.
    Matsumoto M; Kogawa M; Wada S; Takayanagi H; Tsujimoto M; Katayama S; Hisatake K; Nogi Y
    J Biol Chem; 2004 Oct; 279(44):45969-79. PubMed ID: 15304486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calcineurin/NFAT pathway mediates wear particle-induced TNF-α release and osteoclastogenesis from mice bone marrow macrophages in vitro.
    Liu FX; Wu CL; Zhu ZA; Li MQ; Mao YQ; Liu M; Wang XQ; Yu DG; Tang TT
    Acta Pharmacol Sin; 2013 Nov; 34(11):1457-66. PubMed ID: 24056707
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PKCβ positively regulates RANKL-induced osteoclastogenesis by inactivating GSK-3β.
    Shin J; Jang H; Lin J; Lee SY
    Mol Cells; 2014 Oct; 37(10):747-52. PubMed ID: 25256217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action.
    Kim HJ; Kim HJ; Bae MK; Kim YD
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1.
    Song MK; Lee ZH; Kim HH
    Exp Mol Med; 2015 Dec; 47(12):e199. PubMed ID: 26642432
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.
    Mansky KC; Sankar U; Han J; Ostrowski MC
    J Biol Chem; 2002 Mar; 277(13):11077-83. PubMed ID: 11792706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway.
    Tomomura M; Hasegawa H; Suda N; Sakagami H; Tomomura A
    J Biol Chem; 2012 May; 287(22):17963-74. PubMed ID: 22461633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.